NCT03640533 is a NA clinical trial of Nanit-Insights in Infant Sleep Problems, sponsored by Tel Aviv University.

Who is sponsoring NCT03640533?

NCT03640533 is sponsored by Tel Aviv University.

What drugs are being tested in NCT03640533?

Interventions in NCT03640533: Nanit-Insights.

What condition does NCT03640533 study?

NCT03640533 studies Infant Sleep Problems.

Is NCT03640533 still recruiting?

NCT03640533 is currently terminated. Last updated 1 April 2021.

Last reviewed 2021-04-01 · How we verify

NCT03640533

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Efficacy of the Nanit-Insights App in Improving Infant Sleep

Terminated NA Last updated 1 April 2021

What this trial tests

NA trial testing Nanit-Insights in Infant Sleep Problems in 37 participants. Terminated before completion.

Timeline

6 September 2018

Primary endpoint
30 January 2020

30 January 2021

Quick facts

Lead sponsor	Tel Aviv University
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	37
Start date	6 September 2018
Primary completion	30 January 2020
Estimated completion	30 January 2021
Sites	1 location across United States

Drugs / interventions tested

Nanit-Insights

Conditions studied

Infant Sleep Problems — all drugs for Infant Sleep Problems →

Sponsor

Tel Aviv University

Who can join

Adults 5 Months to 7 Months, any sex, with Infant Sleep Problems. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The proposed study aims to examine the effectiveness of Nanit-Insights, an app-based intervention for parents who wish to improve their infant's sleep.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Tel Aviv University trials

Trials by the same sponsor.

NCT07430436 — Improving Self-regulation in Individuals With ADHD Through Adapted Karate Training · NA · not yet recruiting
NCT07426159 — AI-Guided Sarcopenia Risk Assessment and Detection · NA · active not recruiting
NCT07364981 — Gaze Contingent Attentional Reinforcement in Major Depressive Disorder · NA · not yet recruiting
NCT07446127 — Adjunctive Diode Laser Therapy in Non-Surgical Periodontal Therapy · NA · recruiting
NCT06710145 — The Effect of Using the Combat Attention App on the Risk of Post-traumatic Symptoms · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03640533 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tel Aviv University
Last refreshed: 1 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03640533.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing